Search

Search Constraints

You searched for: Author/Creator Grabowski, Matthew M

Search Results

1. Combination Laser Interstitial Thermal Therapy Plus SRS Increases Time to Progression for Recurrent SRS-Treated Brain Metastases. (16th November 2020)

2. Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases. Issue 1 (2nd June 2022)

3. Decreased Circulating Myeloid Derived Suppressor Cells at First Follow-up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM. (1st September 2019)

4. Decreased Circulating Myeloid Derived Suppressor Cells at First Follow‐up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM. (September 2019)

5. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Issue 2 (16th November 2020)

6. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Issue 2 (16th November 2020)

7. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Issue 2 (16th November 2020)

8. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Issue 2 (16th November 2020)

9. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Issue 2 (16th November 2020)

10. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. Issue 2 (16th November 2020)